SOPHiA GENETICS SA Cash And Cash Equivalents
SOPHiA GENETICS SA (SOPH) had Cash And Cash Equivalents of $70.29 million as of 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2026-03-03
- 2025-12-31: Cash And Cash Equivalents $70.29M.
- 2025-06-30: Cash And Cash Equivalents $94.82M.
- 2024-12-31: Cash And Cash Equivalents $80.23M.
- 2024-06-30: Cash And Cash Equivalents $105.40M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-12-31 | $70.29M 20-F · filed 2026-03-03 |
| 2025-06-30 | $94.82M 6-K · filed 2025-08-05 |
| 2024-12-31 | $80.23M 20-F · filed 2026-03-03 |
| 2024-06-30 | $105.40M 6-K · filed 2025-08-05 |
| 2023-12-31 | $123.25M 20-F · filed 2026-03-03 |
| 2023-06-30 | $148.55M 6-K · filed 2024-08-06 |
| 2022-12-31 | $161.31M 20-F · filed 2026-03-03 |
| 2022-06-30 | $178.90M 6-K · filed 2023-08-08 |
| 2021-12-31 | $192.96M 20-F · filed 2025-03-04 |
| 2020-12-31 | $74.63M 20-F · filed 2024-03-05 |
| 2019-12-31 | $18.07M 20-F · filed 2023-03-07 |
| 2018-12-31 | $53.91M 20-F · filed 2022-03-15 |